UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.109

Sortiert nach

Low Sodium Intake — Cardiovascular Health Benefit or Risk?

The New England journal of medicine, 2014-08, Vol.371 (7), p.677-679

Oparil, Suzanne

2014

Volltextzugriff (PDF)

New Approaches in the Treatment of Hypertension

Circulation research, 2015-03, Vol.116 (6), p.1074-1095

2015

Volltextzugriff (PDF)

A Controlled Trial of Renal Denervation for Resistant Hypertension

The New England journal of medicine, 2014-04, Vol.370 (15), p.1393-1401

2014

Volltextzugriff (PDF)

Coffee and Arterial Hypertension

Current hypertension reports, 2021-07, Vol.23 (7), p.38-38, Article 38

2021

Volltextzugriff (PDF)

Treatment of Resistant and Refractory Hypertension

Circulation research, 2019-03, Vol.124 (7), p.1061-1070

2019

Volltextzugriff (PDF)

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes

The New England journal of medicine, 2017-08, Vol.377 (8), p.733-744

2017

Volltextzugriff (PDF)

Updated Guidelines for Management of High Blood Pressure in Japan: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

Hypertension research, 2014-06, Vol.37 (6), p.484-487

Oparil, Suzanne

2014

Volltextzugriff (PDF)

VEGF nanoparticles repair the heart after myocardial infarction

American journal of physiology. Heart and circulatory physiology, 2018-02, Vol.314 (2), p.H278-H284

2018

Volltextzugriff (PDF)

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)

Hypertension (Dallas, Tex. 1979), 2018-05, Vol.71 (5), p.848-857

2018

Volltextzugriff (PDF)

Estrogen and mechanisms of vascular protection

Arteriosclerosis, thrombosis, and vascular biology, 2009-03, Vol.29 (3), p.289

2009

Volltextzugriff (PDF)

Effects of Intensive BP Control in CKD

Journal of the American Society of Nephrology, 2017-09, Vol.28 (9), p.2812-2823

2017

Volltextzugriff (PDF)

Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”

Current hypertension reports, 2021-02, Vol.23 (2), p.7-7, Article 7

2021

Volltextzugriff (PDF)

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2017-08, Vol.377 (8), p.745-755

2017

Volltextzugriff (PDF)

Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines

Current hypertension reports, 2020-08, Vol.22 (9), p.66-66, Article 66

2020

Volltextzugriff (PDF)

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

American journal of kidney diseases, 2017-09, Vol.70 (3), p.357-367

2017

Volltextzugriff (PDF)

Obesity, Hypertension, and Bariatric Surgery

Current hypertension reports, 2020-07, Vol.22 (7), Article 46

2020

Volltextzugriff (PDF)

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

Clinical trials (London, England), 2014-10, Vol.11 (5), p.532-546

2014

Volltextzugriff (PDF)

Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study

Blood pressure, 2018-09, Vol.27 (5), p.247-248

2018

Volltextzugriff (PDF)

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　– Insights From the SYMPLICITY HTN-3 Trial

Circulation Journal, 2016/05/25, Vol.80(6), pp.1404-1412

2016

Volltextzugriff (PDF)

Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β

PloS one, 2012-06, Vol.7 (6), p.e36890

2012

Volltextzugriff (PDF)

Blood Pressure and the Electronic Health Record: A Work in Progress

Journal of the American Heart Association, 2019-06, Vol.8 (12), p.e012960-e012960

2019

Volltextzugriff (PDF)

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

The Lancet (British edition), 2007-07, Vol.370 (9583), p.221-229

2007

Volltextzugriff (PDF)

Preeclampsia—Pathophysiology and Clinical Presentations

Journal of the American College of Cardiology, 2020-10, Vol.76 (14), p.1690-1702

2020

Volltextzugriff (PDF)

Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project

Blood pressure, 2020-05, Vol.29 (3), p.135-136

2020

Volltextzugriff (PDF)

Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?

Blood pressure, 2021-03, Vol.30 (2), p.79-81

2021

Volltextzugriff (PDF)

1 – 25 von 1.109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.055)
Mit Volltextzugriff
(997)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(684)
Life Sciences & Biomedicine
(672)
Humans
(522)
Cardiovascular System & Cardiology
(472)
Peripheral Vascular Disease
(388)
Male
(368)
Female
(324)
Hypertension
(295)
Hypertension - Drug Therapy
(270)
Biological And Medical Sciences
(230)
Animals
(225)
Middle Aged
(211)
Blood Pressure
(206)
Antihypertensive Agents - Therapeutic Use
(198)
Aged
(195)
Medical Sciences
(192)
Hypertension - Physiopathology
(163)
Blood Pressure - Drug Effects
(149)
Cardiac & Cardiovascular Systems
(148)
Rats
(142)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Low Sodium Intake — Cardiovascular Health Benefit or Risk?

New Approaches in the Treatment of Hypertension

A Controlled Trial of Renal Denervation for Resistant Hypertension

Coffee and Arterial Hypertension

Treatment of Resistant and Refractory Hypertension

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes

Updated Guidelines for Management of High Blood Pressure in Japan: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

VEGF nanoparticles repair the heart after myocardial infarction

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)

Estrogen and mechanisms of vascular protection

Effects of Intensive BP Control in CKD

Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

Obesity, Hypertension, and Bariatric Surgery

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　– Insights From the SYMPLICITY HTN-3 Trial

Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β

Blood Pressure and the Electronic Health Record: A Work in Progress

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

Preeclampsia—Pathophysiology and Clinical Presentations

Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project

Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?

Suchergebnisse filtern